跳到正文

Kumar Neil 内部人交易:近期 SEC Form 4 交易

过去 18 个月,Kumar Neil(CIK 1742485)在 1 家公司共报告 174 笔 SEC Form 4 内部人交易(最近一笔 2026-09-21)。

日期公司身份类型股数市值
2026-09-21BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出8,721$601,868
2026-09-21BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,279$88,980
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,900$154,184
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出17,279$1.4M
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出14,602$1.2M
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,199$100,444
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出8,100$679,256
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,800$152,436
2026-08-20BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出100$8,565
2026-08-18BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer买入6,520$0
2026-08-18BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer买入33,544$0
2026-08-18BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer买入11,554$0
2026-08-18BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出36,237$2.9M
2026-08-18BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer买入19,599$0
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出4,416$304,527
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出2,200$144,584
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,429$95,343
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出15,921$1.1M
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出450$30,722
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出2,200$144,584
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出1,429$95,343
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出15,921$1.1M
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出450$30,722
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出7,147$480,278
2026-06-08BridgeBio Pharma, Inc. (BBIO)Chief Executive Officer卖出8,437$572,704

来源:SEC Form 4 申报文件 · 截至 2026-09-21